EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Core Scientific, Inc.
CORZ

CORZ Core Scientific, Inc.

Core Scientific, Inc. · NASDAQ
Market Closed
17.94
▲ ⁦+3.28%⁩ (+0.57)
Market Cap$5.6B
Beta5.59
52w Low52w High
13.3630.46
Last Week
⁦+6.72%⁩
Last Month
⁦-9.21%⁩
Last 3 Months
⁦-30.17%⁩
Last Year
⁦+23.47%⁩
EL7 Factor Analysis
How we score this
Overall3
Poor — bottom quartile of the marketSucker StockF 4/9DistressBetter than 3% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
5
—17.8xBottom tier
▸
Growth
47
26.4%▲7.1%Around median
▸
Quality
31
—4.5%Bottom tier
▸
Safety
13
—2.6xBottom tier
▸
Capital Return
7
—2.12%Bottom tier
▸
Momentum
47
39.6%▲2.9%Around median
▸
Sentiment
74
6▲3Top tier
Fair Value
Low confidenceCurrent price$18
Analyst target · 2 analysts
$36
—
Range ⁦$29–$40⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 2 analysts setting price target
$35.40
⁦+97.3%⁩
Current Price $17.94·Median $36.00
Low
$29.00
High
$40.00
Current price
$17.94
Average target
$35.40
Street summary

Core Scientific (CORZ) Price Target Revision Analysis

Bullish tilt

CORZ stock has seen an improvement in outlook over the past thirty days, with the average price target rising by 5.45% to reach $35.4, driven by the addition of a new analyst covering the stock. This trend reflects growing optimism among analysts, especially with ratings stabilizing at "Buy" and "Outperform" from major institutions such as B. Riley, Needham, and Macquarie, despite a variance in price targets ranging between $29 and $40.

As of 2026-08-10
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 4.12
Buy
Analyst coverage
17
Buy conviction
94%
High
Target dispersion
61%
Wide
Analyst ratings over time17 analysts rating
3
13
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.68 → 4.12
Recent analyst moves
  • = Reiterate2026-08-03
    B. Riley
    Buy
  • = Reiterate2026-07-29
    Wolfe Research
    Buy
  • = Reiterate2026-07-29
    Compass Point
    Buy
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    —
    —
  • Forward P/E
    135.50x
    5.19x41.53x
    Very expensive
  • EV / EBITDA
    —
    —
  • FCF Yield
    -16.7%
    -54.8%10.8%
    Above average
  • Revenue Growth YoY
    26.4%
    -18.1%66.5%
    Above average
  • EPS Growth YoY
    -1176.7%
    -155.3%193.7%
    Weak
  • Gross Margin
    28.3%
    12.9%79.5%
    Below average
  • ROIC
    —
    —
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    -1.39
    -10.9113.66
    Near median
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-05-06 data

Company Overview

Core Scientific is transforming its business model from Bitcoin mining to developing and operating high-density digital infrastructure for hosting artificial intelligence and high-performance computing workloads. The company generates hosting revenue by leasing power and computing capacity under long-term contracts, led by its 12-year CoreWeave contracts, while using its mining operations to help offset contracted energy costs during the transition period. As of May 6, 2026, the company was billing for 243 megawatts of hosting capacity, equivalent to more than $350 million in annual GAAP hosting revenue, compared with a plan to reduce mining to one or two sites by the end of fiscal year 2026.

In Q2 of fiscal year 2026, revenue reached $164.2 million and gross profit was $70.0 million, equivalent to a gross margin of approximately 42.6%, but the net loss reached $1.2 billion and loss per share was $3.32. Compared with Q1 of fiscal year 2026, revenue increased by approximately 42.5% from $115.2 million, gross profit increased by approximately 132.6% from $30.1 million, and gross margin improved from approximately 26.1%, while the net loss widened from $347.2 million.

Revenue for the twelve-month period ending in fiscal year 2026 was approximately $440.3 million, with gross profit of $124.8 million and a net loss of $1.4 billion. The operating mix reflects a shift in the center of gravity toward hosting: the company had delivered 243 billable megawatts to CoreWeave as of May 6, 2026, targeted exceeding 450 megawatts by the end of summer 2026, and planned to deliver the full 590 megawatts of contracted capacity in early 2027, while reducing the number of operating Bitcoin mining machines during the second half of fiscal year 2026.

What's Driving the Stock

  • Core Scientific announced a partnership with AMD on August 3, 2026, to provide artificial intelligence infrastructure with capacity of up to 2.5 gigawatts, a major expansion compared with CoreWeave's contracted capacity of 590 megawatts that strengthens the transition toward high-performance computing.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • The company was generating revenue from approximately 245 megawatts as of May 6, 2026, with revenue generation from an additional 200 megawatts expected to begin during the months following that date. It also raised the target cash gross margin range for the CoreWeave contract from 75%–80% to 80%–85% after gaining clearer visibility into the operating costs of the delivered capacity.
  • On May 6, 2026, the company closed $3.3 billion in financing for CoreWeave projects at an interest rate of 7.75%, with net proceeds of approximately $2.9 billion after closing costs and the debt service reserve. The financing structure provides capital to develop projects outside the CoreWeave assets, with a plan for total capital expenditure of approximately $2 billion during fiscal year 2026.
  • The company is targeting the expansion of both Pecos and Muskogee to approximately 1.5 gigawatts of total capacity, with the construction of an initial 431,000-square-foot, 185-megawatt facility in Pecos and the start of development on an 82.5-megawatt building in Muskogee for initial delivery during the second half of 2027. Core Scientific has secured long-lead equipment for the Pecos project, while the Polaris transaction added approximately 440 megawatts to Muskogee.
  • The exclusivity period related to the Pecos and Muskogee sites ended without a contract being signed, but three hyperscalers entered direct discussions regarding the two sites, and the previous party remained interested in them according to the May 6, 2026 call. Management also said the company was in discussions with hyperscalers, chipmakers, artificial intelligence labs, and specialized cloud providers across a portfolio of five sites targeting readiness of their first halls during 2027.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +The hosting business has demonstrated a tangible ability to become a financial engine, with billable capacity reaching 243 megawatts as of May 6, 2026, equivalent to more than $350 million in annual revenue, while targeting delivery of 590 megawatts to CoreWeave in early 2027.
    • +Operating economics improved clearly between Q1 and Q2 of fiscal year 2026; gross margin increased from approximately 26.1% to 42.6%, and the company raised the target cash gross margin range for the CoreWeave contract to 80%–85%.
    • +The $3.3 billion financing, with net proceeds of approximately $2.9 billion, provides a capital base to accelerate Pecos, Muskogee, Hunt, Dalton Phase III, and Auburn ahead of their commercial readiness. This is complemented by the 2.5-gigawatt scope of the AMD partnership, expanding the company's opportunity beyond the CoreWeave contract.
    • +Core Scientific has tangible execution experience from five high-density sites and more than 150 design modifications, and it had fully delivered the 65-megawatt Marble and 30-megawatt Dalton Phase I facilities before May 6, 2026. This experience may help reduce errors in new modular-design projects compared with more complex conversions of existing sites.

    ▼ Selling Case6 pts

    • −Massive losses represent the most significant financial risk; Core Scientific recorded a net loss of $1.2 billion in Q2 of fiscal year 2026, compared with $347.2 million in Q1, and the twelve-month loss reached $1.4 billion despite generating gross profit of $124.8 million.
    • −The revenue-generating capacity presented on the May 6, 2026 call was largely tied to the CoreWeave contract, as the five sites were leased and financed by this tenant, and the 243 megawatts of delivered capacity and the 590-megawatt target were part of this contract. Therefore, reliance on a major customer and its 12-year contract remains a source of commercial and financing concentration, even as the company seeks to add new customers.
    • −The company plans to spend approximately $2 billion in capital expenditure during fiscal year 2026, including the advance start of approximately one gigawatt of billable capacity and bringing the first data hall to the readiness stage before signing leases for some sites. The expiration of exclusivity for Pecos and Muskogee without a contract illustrates that demand and negotiations do not guarantee that this advance spending will convert into commercial commitments within the targeted timeframe.
    • −Execution remains exposed to construction and supply-chain constraints; management described labor as one of the market's most significant constraints and acknowledged that converting existing sites was more difficult, more complex, and less predictable than expected. Despite securing contractors and long-lead equipment at several sites, delivering more than 450 megawatts by the end of summer 2026 and 590 megawatts in early 2027 requires continued execution without significant delays.
    • −Behind-the-meter power solutions at Pecos and Muskogee require air-quality studies and permits, and management said on May 6, 2026 that it had made progress on the studies but would still be required to submit permit applications for a number of deployments. This adds regulatory and scheduling exposure to expansion plans targeting 1.5 gigawatts at each site.

    Valuation

    The analyst consensus is “Buy,” with an average price target of $35.4 and a target range of $29 to $40; the average is approximately 16.2% above the 52-week range high of $30.46, while the lowest target is approximately 4.8% below that high. No price-to-earnings ratio is available because of the twelve-month net loss of $1.4 billion, so the valuation assumes success in converting financed capacity into hosting contracts and revenue, while the wide target range reflects the risks related to losses, capital expenditure, and execution.

    BuyAnalyst target: $35.4(+97.3%)

    Figures in the text are as of 2026-08-30; the live price is shown at the top of the page.

    FAQ

    What is driving Core Scientific's transition from Bitcoin mining to artificial intelligence hosting?

    Core Scientific was billing for 243 megawatts of hosting capacity as of May 6, 2026, equivalent to more than $350 million in annual GAAP revenue. In contrast, management said the Bitcoin mining business would continue to decline during fiscal year 2026, leaving only one or two sites operating by year-end. The AMD partnership announced on August 3, 2026 reinforced this transition through artificial intelligence infrastructure with capacity of up to 2.5 gigawatts.

    How important is the CoreWeave contract to CORZ's results?

    The CoreWeave contract covers 590 megawatts of contracted capacity across five sites, and the company had delivered 243 billable megawatts as of May 6, 2026. Management targeted exceeding 450 megawatts by the end of summer 2026 and delivering the full capacity in early 2027. It also raised the target cash gross margin range for the contract to 80%–85%, but the reliance of the five leased sites on a single tenant creates clear concentration.

    Why did Core Scientific record a large loss in Q2 of fiscal year 2026?

    EDGAR data showed a net loss of $1.2 billion and a loss per share of $3.32 in Q2 of fiscal year 2026. During the same period, the company generated revenue of $164.2 million and gross profit of $70.0 million, equivalent to a gross margin of approximately 42.6%. The data does not specify a detailed reason for the loss, so it cannot be attributed to a particular accounting or operating item.

    How will Core Scientific finance the Pecos and Muskogee expansions?

    On May 6, 2026, the company closed a $3.3 billion issuance of notes for CoreWeave projects at an interest rate of 7.75%, with net proceeds of approximately $2.9 billion. It plans capital expenditure of approximately $2 billion during fiscal year 2026, including approximately $700 million for the acquisition of the Hunt County site and the Polaris transaction in Muskogee. The company is targeting the expansion of both Pecos and Muskogee to approximately 1.5 gigawatts, using a mix of grid power and behind-the-meter power solutions.

    What are the main execution risks for CORZ's projects during 2026 and 2027?

    Management said on May 6, 2026 that labor represented one of the most significant constraints in the data-center construction market, despite contractors being mobilized at most development sites. The company is also building the first data halls before signing leases at some sites, exposing part of its $2 billion in fiscal year 2026 spending to the risk of contracting delays. Behind-the-meter power solutions at Pecos and Muskogee require air-quality permits, while the first 82.5-megawatt Muskogee building is targeted for initial delivery in the second half of 2027.

    How do analysts view CORZ's stock valuation?

    The analyst consensus is “Buy,” with an average price target of $35.4, a high target of $40, and a low target of $29. The average target exceeds the 52-week range high of $30.46 by approximately 16.2%, while the lowest target is approximately 4.8% below it. There is no comparable price-to-earnings ratio because the twelve-month period in fiscal year 2026 recorded a net loss of $1.4 billion and a loss per share of approximately $4.40.

    −
    No usable price-to-earnings ratio is available because of the losses, while the 52-week range extends from $13.135 to $30.46, making the valuation heavily dependent on the success of the future transition rather than on proven current earnings. Insider activity during the three months ending August 24, 2026 also recorded net sales of $3.1 million, with two purchases and 27 sales; this is a weak trading signal on its own because such sales may be prearranged.